| 83K | Name: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[(1H-indol-3-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide | Formula: | C45 H64 N6 O6 | SMILES: | O=C(CCC(CCc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)N(C)C)N1C(=O)C=C(OC)C1Cc1c[NH]c2ccccc12 | InChi: | InChI=1S/C45H64N6O6/c1-28(2)23-36(48-44(55)37(24-29(3)4)49-45(56)42(30(5)6)50(7)8)43(54)47-33(20-19-31-15-11-10-12-16-31)21-22-40(52)51-38(39(57-9)26-41(51)53)25-32-27-46-35-18-14-13-17-34(32)35/h10-18,26-30,33,36-38,42,46H,19-25H2,1-9H3,(H,47,54)(H,48,55)(H,49,56)/t33-,36-,37-,38-,42-/m0/s1 | Definition date: | 2021-09-03 | Last modified: | 2024-09-27 | Release date: | 2022-03-02 | Identifier: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[(1H-indol-3-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide |
|
| 83N | Name: | tert-butyl-N-[(2S)-1-[(2S,4S)-4-methoxy-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | Formula: | C23 H40 N4 O7 | SMILES: | CO[CH]1C[CH](N(C1)C(=O)[CH](NC(=O)OC(C)(C)C)C(C)C)C(=O)N[CH](CO)C[CH]2CCNC2=O | InChi: | InChI=1S/C23H40N4O7/c1-13(2)18(26-22(32)34-23(3,4)5)21(31)27-11-16(33-6)10-17(27)20(30)25-15(12-28)9-14-7-8-24-19(14)29/h13-18,28H,7-12H2,1-6H3,(H,24,29)(H,25,30)(H,26,32)/t14-,15-,16-,17-,18-/m0/s1 | Synonyms: | tert-butyl-N-[(2S)-1-[(2S,4S)-4-methoxy-2-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | Definition date: | 2021-09-30 | Last modified: | 2024-09-27 | Release date: | 2023-05-03 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-1-[(2~{S},4~{S})-4-methoxy-2-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate |
|
| 83W | Name: | tert-butyl-N-[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2S)-2-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate | Formula: | C25 H44 N4 O7 | SMILES: | C[CH](OC(C)(C)C)[CH](NC(=O)OC(C)(C)C)C(=O)N1CCC[CH]1C(=O)N[CH](CO)C[CH]2CCNC2=O | InChi: | InChI=1S/C25H44N4O7/c1-15(35-24(2,3)4)19(28-23(34)36-25(5,6)7)22(33)29-12-8-9-18(29)21(32)27-17(14-30)13-16-10-11-26-20(16)31/h15-19,30H,8-14H2,1-7H3,(H,26,31)(H,27,32)(H,28,34)/t15-,16+,17+,18+,19+/m1/s1 | Synonyms: | tert-butyl-N-[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2S)-2-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate | Definition date: | 2021-09-30 | Last modified: | 2024-09-27 | Release date: | 2023-05-03 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S},3~{R})-3-[(2-methylpropan-2-yl)oxy]-1-oxidanylidene-1-[(2~{S})-2-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate |
|
| L9U | Name: | 2-bromo-N-[(thiophen-2-yl)methyl]acetamide | Formula: | C7 H8 Br N O S | SMILES: | O=C(NCc1cccs1)CBr | InChi: | InChI=1S/C7H8BrNOS/c8-4-7(10)9-5-6-2-1-3-11-6/h1-3H,4-5H2,(H,9,10) | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 2-bromo-N-[(thiophen-2-yl)methyl]acetamide |
|
| L9Z | Name: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(hydroxyl)cyclohexane-1-carboxylic acid | Formula: | C8 H15 N O5 | SMILES: | NC[C]1(O)C[CH](C[CH](O)[CH]1O)C(O)=O | InChi: | InChI=1S/C8H15NO5/c9-3-8(14)2-4(7(12)13)1-5(10)6(8)11/h4-6,10-11,14H,1-3,9H2,(H,12,13)/t4-,5+,6-,8-/m0/s1 | Definition date: | 2019-08-01 | Last modified: | 2024-09-27 | Release date: | 2020-04-15 | Identifier: | (1~{S},3~{S},4~{S},5~{R})-3-(aminomethyl)-3,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid |
|
| 84C | Name: | tert-butyl-N-[(2S)-1-[(3S,3aS,6aR)-3-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | Formula: | C25 H42 N4 O6 | SMILES: | CC(C)[CH](NC(=O)OC(C)(C)C)C(=O)N1C[CH]2CCC[CH]2[CH]1C(=O)N[CH](CO)C[CH]3CCNC3=O | InChi: | InChI=1S/C25H42N4O6/c1-14(2)19(28-24(34)35-25(3,4)5)23(33)29-12-16-7-6-8-18(16)20(29)22(32)27-17(13-30)11-15-9-10-26-21(15)31/h14-20,30H,6-13H2,1-5H3,(H,26,31)(H,27,32)(H,28,34)/t15-,16-,17-,18-,19-,20-/m0/s1 | Synonyms: | tert-butyl N-[(2S)-1-[(3S,3aS,6aR)-3-[[(2S)-1-oxidanylidene-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate | Definition date: | 2021-09-30 | Last modified: | 2024-09-27 | Release date: | 2023-05-03 | Identifier: | ~{tert}-butyl ~{N}-[(2~{S})-1-[(3~{S},3~{a}~{S},6~{a}~{R})-3-[[(2~{S})-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]carbamoyl]-3,3~{a},4,5,6,6~{a}-hexahydro-1~{H}-cyclopenta[c]pyrrol-2-yl]-3-methyl-1-oxidanylidene-butan-2-yl]carbamate |
|
| LAF | Name: | 5-FLUOROLEVULINIC ACID | Formula: | C5 H7 F O3 | SMILES: | FCC(=O)CCC(=O)O | InChi: | InChI=1S/C5H7FO3/c6-3-4(7)1-2-5(8)9/h1-3H2,(H,8,9) | Definition date: | 2002-05-21 | Last modified: | 2024-09-27 | Identifier: | 5-fluoro-4-oxopentanoic acid |
|
| 85G | Name: | N-ethyl-L-glutamine | Formula: | C7 H14 N2 O3 | SMILES: | NC(C(O)=O)CCC(NCC)=O | InChi: | InChI=1S/C7H14N2O3/c1-2-9-6(10)4-3-5(8)7(11)12/h5H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1 | Definition date: | 2017-01-05 | Last modified: | 2024-09-27 | Release date: | 2017-05-24 | Identifier: | N-ethyl-L-glutamine |
|
| 85J | Name: | N-propyl-L-glutamine | Formula: | C8 H16 N2 O3 | SMILES: | NC(CCC(NCCC)=O)C(O)=O | InChi: | InChI=1S/C8H16N2O3/c1-2-5-10-7(11)4-3-6(9)8(12)13/h6H,2-5,9H2,1H3,(H,10,11)(H,12,13)/t6-/m0/s1 | Definition date: | 2017-01-05 | Last modified: | 2024-09-27 | Release date: | 2017-05-24 | Identifier: | N-propyl-L-glutamine |
|
| 85L | Name: | [[(2~{R})-2-azanyl-3-oxidanylidene-propyl]-(chloranylaurio)sulfanuidyl]-chloranyl-gold | Formula: | C3 H6 Au2 Cl2 N O2 S | SMILES: | N[CH](C[S-]([Au]Cl)[Au]Cl)C(O)=O | InChi: | InChI=1S/C3H7NO2S.2Au.2ClH/c4-2(1-7)3(5)6 | Definition date: | 2021-10-01 | Last modified: | 2024-09-27 | Release date: | 2023-04-19 | Identifier: | [[(2~{R})-2-azanyl-3-oxidanyl-3-oxidanylidene-propyl]-(chloranylaurio)sulfanuidyl]-chloranyl-gold |
|
| LBF | Name: | Leptomycin B | Formula: | C33 H48 O6 | SMILES: | O=C(O)C=C(/C)CC(C)C(O)C(C(=O)C(/C=C(/C=C/CC(/C=C(C=CC1OC(=O)C=CC1C)CC)C)C)C)C | InChi: | InChI=1S/C33H48O6/c1-9-28(14-15-29-24(5)13-16-31(36)39-29)19-22(3)12-10-11-21(2)17-25(6)32(37)27(8)33(38)26(7)18-23(4)20-30(34)35/h10-11,13-17,19-20,22,24-27,29,33,38H,9,12,18H2,1-8H3,(H,34,35)/b11-10+,15-14+,21-17+,23-20+,28-19-/t22-,24+,25-,26+,27-,29+,33-/m1/s1 | Definition date: | 2012-10-11 | Last modified: | 2024-09-27 | Release date: | 2013-01-04 | Identifier: | (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-[(2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid |
|
| LBI | Name: | 4-methoxy-1H-indole-2-carbaldehyde | Formula: | C10 H9 N O2 | SMILES: | COc1cccc2[NH]c(cc21)C=O | InChi: | InChI=1S/C10H9NO2/c1-13-10-4-2-3-9-8(10)5-7(6-12)11-9/h2-6,11H,1H3 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-12-07 | Identifier: | 4-methoxy-1H-indole-2-carbaldehyde |
|
| 85P | Name: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid | Formula: | C16 H9 Cl F N O5 S | SMILES: | c1(ccc3c(c1)c(C(O)=O)cc(c2ccc(cc2)Cl)n3)OS(F)(=O)=O | InChi: | InChI=1S/C16H9ClFNO5S/c17-10-3-1-9(2-4-10)15-8-13(16(20)21)12-7-11(24-25(18,22)23)5-6-14(12)19-15/h1-8H,(H,20,21) | Definition date: | 2017-01-05 | Last modified: | 2024-09-27 | Release date: | 2018-01-17 | Identifier: | 2-(4-chlorophenyl)-6-[(fluorosulfonyl)oxy]quinoline-4-carboxylic acid |
|
| 85Q | Name: | (2R,4R)-1-(2-chloranylethanoyl)-N-(3-chlorophenyl)-4-phenyl-pyrrolidine-2-carboxamide | Formula: | C19 H18 Cl2 N2 O2 | SMILES: | ClCC(=O)N1C[CH](C[CH]1C(=O)Nc2cccc(Cl)c2)c3ccccc3 | InChi: | InChI=1S/C19H18Cl2N2O2/c20-11-18(24)23-12-14(13-5-2-1-3-6-13)9-17(23)19(25)22-16-8-4-7-15(21)10-16/h1-8,10,14,17H,9,11-12H2,(H,22,25)/t14-,17+/m0/s1 | Definition date: | 2021-10-04 | Last modified: | 2024-09-27 | Release date: | 2022-10-05 | Identifier: | (2~{R},4~{R})-1-(2-chloranylethanoyl)-~{N}-(3-chlorophenyl)-4-phenyl-pyrrolidine-2-carboxamide |
|
| 862 | Name: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one | Formula: | C23 H25 N9 O2 | SMILES: | CCC(=O)N1CCC[CH](C1)n2nc(c3cn(nn3)c4ccc(cc4)C(C)=O)c5c(N)ncnc25 | InChi: | InChI=1S/C23H25N9O2/c1-3-19(34)30-10-4-5-17(11-30)32-23-20(22(24)25-13-26-23)21(28-32)18-12-31(29-27-18)16-8-6-15(7-9-16)14(2)33/h6-9,12-13,17H,3-5,10-11H2,1-2H3,(H2,24,25,26)/t17-/m1/s1 | Definition date: | 2018-11-28 | Last modified: | 2024-09-27 | Release date: | 2019-02-27 | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-[1-(4-ethanoylphenyl)-1,2,3-triazol-4-yl]pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one |
|
| LBX | Name: | (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline | Formula: | C8 H11 N O5 | SMILES: | O=C(CCO)C(N=CCC=O)C(=O)O | InChi: | InChI=1S/C8H11NO5/c10-4-1-3-9-7(8(13)14)6(12)2-5-11/h3-4,7,11H,1-2,5H2,(H,13,14)/b9-3+/t7-/m0/s1 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-05-25 | Identifier: | (E)-5-hydroxy-3-oxo-N-(3-oxopropylidene)-L-norvaline |
|
| LBZ | Name: | (2~{S})-2-azanyl-6-benzamido-hexanoic acid | Formula: | C13 H18 N2 O3 | SMILES: | N[CH](CCCCNC(=O)c1ccccc1)C(O)=O | InChi: | InChI=1S/C13H18N2O3/c14-11(13(17)18)8-4-5-9-15-12(16)10-6-2-1-3-7-10/h1-3,6-7,11H,4-5,8-9,14H2,(H,15,16)(H,17,18)/t11-/m0/s1 | Definition date: | 2020-01-22 | Last modified: | 2024-09-27 | Release date: | 2020-11-18 | Identifier: | (2~{S})-2-azanyl-6-benzamido-hexanoic acid |
|
| 868 | Name: | S-[2-[3-[[(2S)-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] (2R)-2-azanylpropanethioate | Formula: | C14 H28 N3 O8 P S | SMILES: | C[CH](N)C(=O)SCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(O)=O | InChi: | InChI=1S/C14H28N3O8PS/c1-9(15)13(21)27-7-6-16-10(18)4-5-17-12(20)11(19)14(2,3)8-25-26(22,23)24/h9,11,19H,4-8,15H2,1-3H3,(H,16,18)(H,17,20)(H2,22,23,24)/t9-,11-/m1/s1 | Definition date: | 2022-03-02 | Last modified: | 2024-09-27 | Release date: | 2022-07-13 | Identifier: | ~{S}-[2-[3-[[(2~{S})-3,3-dimethyl-2-oxidanyl-4-phosphonooxy-butanoyl]amino]propanoylamino]ethyl] (2~{R})-2-azanylpropanethioate |
|
| 86F | Name: | (3~{S})-1-(iminomethyl)-~{N}-pent-4-ynyl-pyrrolidine-3-carboxamide | Formula: | C12 H19 N3 O S | SMILES: | CSC(=N)N1CC[CH](C1)C(=O)NCCCC#C | InChi: | InChI=1S/C12H19N3OS/c1-3-4-5-7-14-11(16)10-6-8-15(9-10)12(13)17-2/h1,10,13H,4-9H2,2H3,(H,14,16)/b13-12-/t10-/m0/s1 | Definition date: | 2023-07-10 | Last modified: | 2024-09-27 | Release date: | 2024-01-31 | Identifier: | methyl (3~{S})-3-(pent-4-ynylcarbamoyl)pyrrolidine-1-carboximidothioate |
|
| 86M | Name: | 5-[(imidazo[1,2-a]pyridin-8-yl)methoxy]-2-methoxypyridine-4-carbaldehyde | Formula: | C15 H13 N3 O3 | SMILES: | c2cn3ccnc3c(COc1cnc(OC)cc1C=O)c2 | InChi: | InChI=1S/C15H13N3O3/c1-20-14-7-12(9-19)13(8-17-14)21-10-11-3-2-5-18-6-4-16-15(11)18/h2-9H,10H2,1H3 | Definition date: | 2017-01-09 | Last modified: | 2024-09-27 | Release date: | 2017-02-22 | Identifier: | 5-[(imidazo[1,2-a]pyridin-8-yl)methoxy]-2-methoxypyridine-4-carbaldehyde |
|
| 86N | Name: | (2S)-5-[[5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)furan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-2-azanyl-5-oxidanylidene-pentanoic acid | Formula: | C15 H17 N6 O10 P | SMILES: | N[CH](CCC(=O)O[P](O)(=O)OCc1oc(n2cnc3c(N)ncnc23)c(O)c1O)C(O)=O | InChi: | InChI=1S/C15H17N6O10P/c16-6(15(25)26)1-2-8(22)31-32(27,28)29-3-7-10(23)11(24)14(30-7)21-5-20-9-12(17)18-4-19-13(9)21/h4-6,23-24H,1-3,16H2,(H,25,26)(H,27,28)(H2,17,18,19)/t6-/m0/s1 | Definition date: | 2021-10-04 | Last modified: | 2024-09-27 | Release date: | 2021-10-27 | Identifier: | (2~{S})-5-[[5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)furan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-2-azanyl-5-oxidanylidene-pentanoic acid |
|
| LCK | Name: | (Z)-N~6~-(2-carboxy-1-methylethylidene)-L-lysine | Formula: | C10 H18 N2 O4 | SMILES: | O=C(O)CC(=N/CCCCC(N)C(=O)O)C | InChi: | InChI=1S/C10H18N2O4/c1-7(6-9(13)14)12-5-3-2-4-8(11)10(15)16/h8H,2-6,11H2,1H3,(H,13,14)(H,15,16)/b12-7-/t8-/m0/s1 | Definition date: | 2008-02-15 | Last modified: | 2024-09-27 | Identifier: | (Z)-N~6~-(2-carboxy-1-methylethylidene)-L-lysine |
|
| LCW | Name: | 2-[4-[(6-ethenyl-9~{H}-purin-2-yl)amino]phenyl]ethanamide | Formula: | C15 H14 N6 O | SMILES: | NC(=O)Cc1ccc(Nc2nc3[nH]cnc3c(C=C)n2)cc1 | InChi: | InChI=1S/C15H14N6O/c1-2-11-13-14(18-8-17-13)21-15(20-11)19-10-5-3-9(4-6-10)7-12(16)22/h2-6,8H,1,7H2,(H2,16,22)(H2,17,18,19,20,21) | Definition date: | 2019-08-05 | Last modified: | 2024-09-27 | Release date: | 2020-06-17 | Identifier: | 2-[4-[(6-ethenyl-9~{H}-purin-2-yl)amino]phenyl]ethanamide |
|
| LCY | Name: | 1-methylpyrrolidine-2,5-dione | Formula: | C5 H7 N O2 | SMILES: | O=C1N(C(=O)CC1)C | InChi: | InChI=1S/C5H7NO2/c1-6-4(7)2-3-5(6)8/h2-3H2,1H3 | Definition date: | 2009-05-22 | Last modified: | 2024-09-27 | Identifier: | 1-methylpyrrolidine-2,5-dione |
|
| LD0 | Name: | (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid | Formula: | C14 H19 N5 O5 S3 | SMILES: | SCC1CSC(NC1C(=O)O)C(C=O)NC(=O)C(=NOC)/c1csc(N)n1 | InChi: | InChI=1S/C14H19N5O5S3/c1-24-19-10(8-5-27-14(15)17-8)11(21)16-7(2-20)12-18-9(13(22)23)6(3-25)4-26-12/h2,5-7,9,12,18,25H,3-4H2,1H3,(H2,15,17)(H,16,21)(H,22,23)/b19-10-/t6-,7-,9+,12-/m1/s1 | Definition date: | 2022-03-01 | Last modified: | 2024-09-27 | Release date: | 2022-05-25 | Identifier: | (2R,4S,5R)-2-[(1R)-1-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-5-(sulfanylmethyl)-1,3-thiazinane-4-carboxylic acid |
|